Study Exclusion reasons Remarks Reference(s)
NRG Oncology GY004, 0 randomized controlled trial

JF Liu, MF Brady, UA Matulonis, et al. Proc Am Soc Clin Oncol, 38 (suppl 15) (2020), Article 6003 (abstr)

Liu JF J Clin Oncol 2022 Jul 1;40(19):2138-2147. 10.1200/JCO.21.02011